|
|
|
|
|
非在研适应症- |
最高研发阶段批准上市 |
|
首次获批日期1984-06-28 |
Glycemic Control with Triple Pathway Approach Through Empagliflozin-Linagliptin-Metformin
The efficacy and safety of a triple-pill combination therapy for advanced type 2 diabetes care. The study aims to assess the impact of 3 Oral Anti Diabetic (OAD) drugs on metabolic control, patient compliance, weight management, quality of life, diabetic treatment satisfaction and frequency of hypoglycemic events by combining them into a fixed-dose single pill.
Misoprostol for Non-alcoholic Steatohepatitis- a Randomized Control Trial
The aim of this randomised control trial is to evaluate the effect of Misoprostol in treating patients with NASH.
Efficacy and Safety Study of Fixed Dose Combination Tablet of Iron Polymaltose and Folic Acid (Tablet Irpo- FA®) in Pregnant Women with Iron Deficiency Anaemia.
100 项与 Nabiqasim Industries (Pvt) Ltd 相关的临床结果
0 项与 Nabiqasim Industries (Pvt) Ltd 相关的专利(医药)
100 项与 Nabiqasim Industries (Pvt) Ltd 相关的药物交易
100 项与 Nabiqasim Industries (Pvt) Ltd 相关的转化医学